未找到相关数据
Efficacy of cabozantinib (C) vs everolimus (E) in patients (pts) with advanced renal cell carcinoma (RCC) and bone metastases (mets) from the phase III METEOR study
被引：5
作者：
Escudier, Bernard J.
Powles, Thomas
Motzer, Robert J.
Olencki, Thomas
Aren, Osvaldo Rudy
Oudard, Stephane
Bracarda, Sergio
Tomczak, Piotr
Castellano, Daniel E.
Appleman, Leonard Joseph
Drabkin, Harry A.
Vaena, Daniel A.
Milwee, Steven
Youkstetter, Jillian
Choueiri, Toni K.
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Queen Mary Univ London, Barts Canc Inst, London, England
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[5] Ctr Int Estudios Clin, Santiago, Chile
[6] Hop Europeen Georges Pompidou, Dept Med Oncol, Paris, France
[7] Ist Toscano Tumori, Florence, Italy
[8] Oddzial Chemioterapii, Klin Onkol, Poznan, Poland
[9] Hosp Univ 12 Octubre, Madrid, Spain
[10] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[11] Med Univ South Carolina, Charleston, SC 29425 USA
[12] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[13] Exelixis Inc, San Francisco, CA USA
[14] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 [肿瘤学];
摘要：
4558
引用
收藏
页数：2
相关论文